Literature DB >> 18295661

Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Hua Shen1, Yu Zhu, Yu-Jie Wu, Hai-Rong Qiu, Yong-Qian Shu.   

Abstract

We used two molecular cytogenetic techniques, multicolor fluorescence in situ hybridization (M-FISH) and comparative genomic hybridization (CGH), to analyze three established lung adenocarcinoma cell lines (A549, H1650, and SPC-A-1) and primary lung adenocarcinoma samples, to identify common chromosomal aberrations. M-FISH revealed numerous complex chromosomal rearrangements. Chromosomes 5, 6, 11, 12, and 17 were most frequently involved in interchromosomal translocations. CGH revealed regions on 1q, 2p, 3q, 5p, 5q, 7p, 8q, 11q, 12q, 14q, 16p, 17p, 19q, 20q, 21q, and 22q to be commonly overrepresented and regions on 2q, 3p, 4p, 5q, 7q, 8p, 9p, 13q, 14q, and 17p to be underrepresented. The most common gains were found in 16p13 (in 50% of samples), and 16p13 amplification was associated with relatively poor differentiation and late stage. M-FISH and CGH can be a powerful tool in identification of genomic alterations in lung cancer, as well as in diagnosis. The overrepresented regions may harbor potential candidate genes involved in lung adenocarcinoma pathogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18295661     DOI: 10.1016/j.cancergencyto.2007.11.012

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

1.  [Combined treatment with myo-inositol and luteolin selectively suppresses growth of human lung cancer A549 cells possibly by suppressing activation of PDK1 and Akt].

Authors:  Yun Wang; Yuyuan Zhang; Xue Chen; Yun Hong; Zhengdong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

2.  Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.

Authors:  Thomas Harris; Qiulu Pan; Juan Sironi; Dionne Lutz; Jianmin Tian; Jana Sapkar; Roman Perez-Soler; Steven Keller; Joseph Locker
Journal:  Clin Cancer Res       Date:  2010-12-10       Impact factor: 12.531

3.  The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.

Authors:  Khalil A Choucair; Karl-Philippe Guérard; Joshua Ejdelman; Simone Chevalier; Maisa Yoshimoto; Eleonora Scarlata; Ladan Fazli; Kanishka Sircar; Jeremy A Squire; Fadi Brimo; Isabela W Cunha; Armen Aprikian; Martin Gleave; Jacques Lapointe
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

4.  Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.

Authors:  Felix H Shek; Sarwat Fatima; Nikki P Lee
Journal:  Int J Hepatol       Date:  2012-09-18

5.  CEMP1 Induces Transformation in Human Gingival Fibroblasts.

Authors:  Mercedes Bermúdez; Ivan Imaz-Rosshandler; Claudia Rangel-Escareño; Margarita Zeichner-David; Higinio Arzate; Gabriela E Mercado-Celis
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 6.  Roles of eukaryotic initiation factor 5A2 in human cancer.

Authors:  Feng-wei Wang; Xin-yuan Guan; Dan Xie
Journal:  Int J Biol Sci       Date:  2013-10-12       Impact factor: 6.580

7.  Focus on 16p13.3 Locus in Colon Cancer.

Authors:  Evi Mampaey; Annelies Fieuw; Thalia Van Laethem; Liesbeth Ferdinande; Kathleen Claes; Wim Ceelen; Yves Van Nieuwenhove; Piet Pattyn; Marc De Man; Kim De Ruyck; Nadine Van Roy; Karen Geboes; Stéphanie Laurent
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

8.  Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.

Authors:  M Scortegagna; C Ruller; Y Feng; R Lazova; H Kluger; J-L Li; S K De; R Rickert; M Pellecchia; M Bosenberg; Z A Ronai
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

9.  An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.

Authors:  Lucy F Stead; Philip Egan; Aoife Devery; Caroline Conway; Catherine Daly; Stefano Berri; Henry Wood; Ornella Belvedere; Kostas Papagiannopoulos; Anderson Ryan; Pamela Rabbitts
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 10.  Prognostic factors in resected lung carcinomas.

Authors:  Keith M Kerr; Marianne C Nicolson
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.